Pacer Advisors Inc. Has $205.38 Million Stock Position in Colgate-Palmolive Company $CL

Pacer Advisors Inc. lessened its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 3.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,599,054 shares of the company’s stock after selling 97,993 shares during the period. Pacer Advisors Inc. owned about 0.32% of Colgate-Palmolive worth $205,377,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of CL. HighPoint Advisor Group LLC increased its position in shares of Colgate-Palmolive by 0.7% during the 4th quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock worth $1,255,000 after purchasing an additional 109 shares during the last quarter. Clear Harbor Asset Management LLC boosted its holdings in shares of Colgate-Palmolive by 2.6% in the 4th quarter. Clear Harbor Asset Management LLC now owns 4,503 shares of the company’s stock valued at $356,000 after buying an additional 113 shares during the last quarter. Moneta Group Investment Advisors LLC grew its stake in shares of Colgate-Palmolive by 0.7% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,506 shares of the company’s stock valued at $1,225,000 after buying an additional 114 shares in the last quarter. Sunpointe LLC grew its stake in shares of Colgate-Palmolive by 4.0% in the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock valued at $241,000 after buying an additional 117 shares in the last quarter. Finally, Triumph Capital Management increased its holdings in Colgate-Palmolive by 62.9% during the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after buying an additional 127 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

CL opened at $89.74 on Friday. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. The business has a fifty day simple moving average of $87.32 and a 200 day simple moving average of $86.58. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The company has a market capitalization of $71.81 billion, a PE ratio of 34.92, a price-to-earnings-growth ratio of 4.78 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.91 EPS. Research analysts expect that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. Colgate-Palmolive’s payout ratio is currently 82.49%.

Wall Street Analyst Weigh In

A number of analysts have commented on CL shares. Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a research note on Monday, May 4th. Barclays boosted their price objective on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 5th. Sanford C. Bernstein initiated coverage on Colgate-Palmolive in a report on Thursday, June 11th. They set a “market perform” rating and a $96.00 price target for the company. Wells Fargo & Company cut their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 8th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.